Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Amplex Red for Reliable Cell Redox Assays
2026-09-11
Learn how Amplex Red (SKU C4839) can strengthen hydrogen peroxide measurements alongside cell viability, proliferation, and cytotoxicity workflows. This scenario-based guide covers assay compatibility, handling, optical settings, interpretation, and practical vendor-selection criteria.
-
Moxifloxacin Workflows for Gyrase and Toxicity
2026-09-11
Moxifloxacin connects DNA gyrase biology with practical cell-based and in vivo toxicity workflows. This guide combines formulation guidance, dose-anchored assay design, mechanistic comparison with gepotidacin, and troubleshooting for more reproducible antibiotic toxicity research.
-
7-dehydro Cholesterol: DHCR7 Workflow Guide
2026-09-10
Use 7-dehydro Cholesterol to connect DHCR7-dependent sterol flux with UVB-driven vitamin D3 formation, oxidative lipid signaling, and disease-model phenotypes. This workflow guide separates substrate supplementation from genetic knockout evidence and provides practical handling, dosing, validation, and troubleshooting strategies.
-
Vacuolin-1: From Fusion Blockade to Causal Biology
2026-09-10
Vacuolin-1 is a selective lysosomal exocytosis inhibitor for separating lysosome–plasma membrane fusion from downstream disease phenotypes. This article develops an assay framework linking β-hexosaminidase release, calcium signaling, growth-factor disruption, and membrane repair research.
-
Dacomitinib (PF-00299804) Assay Guide
2026-09-09
A scenario-based guide to using Dacomitinib (PF-00299804), SKU A8319, in cell viability, proliferation, and cytotoxicity workflows. It connects ErbB pharmacology, solvent handling, ferroptosis-aware interpretation, dose–response design, and practical product-selection criteria.
-
CP-673451: A Translational PDGFRα/β Strategy
2026-09-09
CP-673451 offers a focused way to interrogate PDGFRα/β signaling, angiogenesis, and tumor biology. This article connects its biochemical selectivity and preclinical activity with ATRX-informed glioma research, biomarker strategy, and translational study design.
-
Amplex Red Assay: Workflow, Uses, and Troubleshooting
2026-09-08
Amplex Red converts hydrogen peroxide formation into a sensitive resorufin fluorescence signal for enzyme kinetics, ROS studies, and inhibitor screening. This guide combines a practical plate-based workflow with controls for false positives, matrix interference, and cross-domain assay design.
-
Ibrexafungerp (MK 3118): Mechanism & Evidence
2026-09-08
Ibrexafungerp, also called MK 3118, is an oral triterpenoid glucan synthase inhibitor with activity against Candida isolates under acidic vaginal conditions. Clinical and laboratory evidence supports its use in vulvovaginal candidiasis research, while invasive candidiasis applications remain translational and investigational.
-
Galectin-1, FIP200, and Autophagy in Steatosis
2026-09-07
The 2026 reference study identifies a Galectin-1–FIP200 interaction as an upstream mechanism that suppresses autophagy and promotes hepatic steatosis, dyslipidemia, and insulin resistance. Its combination of in vivo metabolic phenotyping, proteomic analysis, interaction mapping, binding measurements, and interface-disrupting mutations provides a mechanistic framework for studying autophagy control in metabolic liver disease.
-
Amplex Red for Reliable H2O2 Assays
2026-09-07
Amplex Red converts hydrogen peroxide formation into a sensitive resorufin fluorescence signal for mitochondrial, cellular, oxidase, and peroxidase workflows. This guide pairs practical assay design with a critical carboxylesterase control that can prevent false-positive oxidative stress measurements.
-
Moxifloxacin: Gyrase Mechanism and Research Uses
2026-09-05
Moxifloxacin is a fluoroquinolone antibiotic that disrupts bacterial DNA processing through DNA gyrase inhibition. Product-reported benchmarks also support its use in antibiotic toxicity research, including retinal ganglion cell assays and dose-dependent metabolic-response studies.
-
Amplex Red Assays: Workflows, Uses, and Optimization
2026-09-04
Amplex Red converts low-level hydrogen peroxide and peroxidase activity into a measurable resorufin fluorescence signal, making it useful for cell assays, enzyme kinetics, and screening. This practical guide translates a cytochrome P450 engineering study into scalable assay design, with starting conditions and troubleshooting for reliable reactive oxygen species measurements.
-
Tomivosertib Workflows for MNK1 Inhibition
2026-09-04
Tomivosertib enables researchers to connect MNK1/2 target engagement with eIF4E phosphorylation, cancer-cell phenotypes, neuronal activity, and metabolic translation. This workflow-focused guide shows how to choose concentrations, pair molecular and functional readouts, and troubleshoot context-dependent results.
-
LY-411575: From Secretase Control to Translation
2026-09-03
LY-411575 connects amyloid biology with Notch-dependent tumor immunology. This thought-leadership analysis examines its mechanistic value, experimental boundaries, formulation considerations, and translational relevance for Alzheimer’s disease research and cancer research, including how recent TNBC findings reshape the case for pathway-aware gamma-secretase inhibition.
-
Cap 1 mRNA as a Translational Delivery Probe
2026-09-03
A thought-leadership perspective on using Cap 1 firefly luciferase mRNA to separate delivery, cytosolic release, translation, and cell-state effects, informed by recent IDP-inspired coacervate research.